Clinical trial
GW823093 Japan Phase IIa Mono
NCT00370942 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- GW823093 Japan Phase IIa Mono
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- April 1, 2006
- Completion date
- November 25, 2006
- Enrollment
- 159 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.